Related Experiment Video
Updated: Jan 10, 2026

Breakfast Habits among Schoolchildren in the City of Uruguaiana, Brazil
Published on: July 29, 2020
Porphyria cutanea tarda in children: epidemiological study of a rare disease in Argentina
Manuel Mendez1,2, Laura Varela1, Viviana Melito1,3
1Centro de Investigaciones sobre Porfirinas y Porfirias (CIPYP), Universidad de Buenos Aires-CONICET, Buenos Aires, Argentina.
Introduction:
Porphyria cutanea tarda (PCT), the most common porphyria, is caused by a decreased activity of uroporphyrinogen decarboxylase (UROD). PCT is generally sporadic, but in about 25% of cases, the disease is transmitted as an autosomal dominant trait (familial PCT). Few cases of PCT with onset in childhood have been reported to date. The aim was to perform a retrospective analysis of these rare cases, including all patients diagnosed with PCT from 1977 to present, with disease onset occurring before the age of 18.
Materials And Methods:
We analyzed 28 patients, 15 males and 13 females, ranging from 3 to 16 years old.
Results:
Characteristic biochemical alterations, such as elevated urinary levels of porphyrins with typical excretion pattern, high plasma porphyrin index, reduced erythrocyte UROD activity, and typical cutaneous lesions of PCT were observed in all patients. Molecular analysis revealed the genetic heterogeneity inherent to PCT, with certain variants being prominent within the Argentinian cohort. Potential precipitating factors of the disease were also described.
Discussion:
This study provides a comprehensive analysis of childhood-onset PCT in the Argentinian population, shedding light on both genetic and environmental factors contributing to the disease. We emphasize the crucial need for early diagnosis, particularly in pediatric cases, and remark on the importance of genetic studies among family members to prevent the delayed recognition of PCT in high-risk individuals. Additionally, the study discusses the role of environmental factors in disease onset and the importance of carefully monitoring drug use in PCT patients.
More Related Videos
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
07:50A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Excretion
Protein Import into the Peroxisomes
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Pharmacokinetics in Pediatric Patients: Drug Distribution
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...